This perspective traces developments using monoclonal antibody technology that led to the discovery of CD40, a receptor that on B cells mediates "T cell help" and on dendritic cells helps to program CD8 T cell responses. I discuss some things that we got right during the path of discovery and some things we missed. Immunotherapies that block or stimulate the CD40 pathway hold great promise for treatment of autoimmune diseases and cancers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4179537 | PMC |
| http://dx.doi.org/10.3389/fimmu.2014.00472 | DOI Listing |
Publication Analysis
Top Keywords
short history
4
history b-cell-associated
4
b-cell-associated surface
4
surface molecule
4
molecule cd40
4
cd40 perspective
4
perspective traces
4
traces developments
4
developments monoclonal
4
monoclonal antibody
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!